scispace - formally typeset
A

Assuero Giorgetti

Researcher at University of Pisa

Publications -  100
Citations -  2588

Assuero Giorgetti is an academic researcher from University of Pisa. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 25, co-authored 93 publications receiving 2359 citations. Previous affiliations of Assuero Giorgetti include University of Genoa & National Research Council.

Papers
More filters
Journal ArticleDOI

Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction

TL;DR: It is demonstrated that severely depressed MBF is a predictor of poor prognosis in patients with idiopathic LV dysfunction independently of the degree of LV functional impairment and of the presence of overt heart failure.
Journal ArticleDOI

Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure A Quantitative Assessment by Positron Emission Tomography

TL;DR: In patients with DCM without overt heart failure, the abnormalities in vasodilating capability can be present despite normal hemodynamics; progression of the disease is associated with more depressed myocardial perfusion.
Journal ArticleDOI

Homogeneously Reduced Versus Regionally Impaired Myocardial Blood Flow in Hypertensive Patients: Two Different Patterns of Myocardial Perfusion Associated With Degree of Hypertrophy

TL;DR: In arterial hypertension, left ventricular mass is not correlated with global myocardial blood flow, and patients with ventricular hypertrophy are likely to show a heterogeneous flow pattern with regional defects and almost normal blood flow in nonaffected regions.
Journal ArticleDOI

High diagnostic accuracy of low-dose gated-SPECT with solid-state ultrafast detectors: preliminary clinical results

TL;DR: This pilot study demonstrated the feasibility of a low-dose single-day stress–rest fasting protocol performed using UF SPECT, with good sensitivity and specificity in detecting CAD at low patient exposure, opening new perspectives in the use of myocardial perfusion in ischaemic patients.
Journal ArticleDOI

Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients.

TL;DR: Semiquantitative FDG-PET scanning of metastatic breast cancer sites showed a rapid and significant decrease in tumor glucose metabolism soon after the first course of treatment in patients who achieved a response to first-line chemotherapy, while no significant decrease was observed in nonresponding patients.